Dr Argyro Papadopoulou MBChB

Dr Argyro Papadopoulou

Institute of Metabolism and Systems Research
PhD student

Contact details

Address
WHO Collaborating Centre for Global Women’s Health Research
Institute of Metabolism and Systems Research
University of Birmingham
Edgbaston
Birmingham
B15 2TT
UK

Argyro Papadopoulou graduated with honors from the Medical School of the University of Athens, Greece. In 2018, she joined the Institute of Metabolism and Systems Research at the University of Birmingham and is currently working towards a PhD. The title of her PhD thesis is "Doses and routes of administration for uterotonic agents to prevent postpartum haemorrhage". Her PhD is supervised by Professor Arri Coomarasamy and Dr Ioannis D Gallos and is funded through the Tommy's National Centre for Miscarriage Research.

Qualifications

  • Full registration with licence to practice, General Medical Council, Greece, 2016
  • MBChB, National & Kapodistrian University of Athens, Greece, 2016

Biography

Argyro is physician who aims to specialize in Obstetrics and Gynaecology. She completed her MBChB at National and Kapodistrian University of Athens, Greece. After graduating she moved to the West Midlands to gain work experience at Birmingham Women’s and Children’s Hospital NHS Foundation Trust. In 2018, Argyro started working as a researcher at the Institute of Metabolism and Systems Research at the University of Birmingham.

Research

Argyro’s research focuses on the prevention and treatment of postpartum haemorrhage, which remains the leading cause of maternal mortality worldwide. She is also interest in global maternal health and early pregnancy.

Publications

Coomarasamy A, Gallos ID, Papadopoulou A, Dhillon-Smith RK, Al-Memar M, Brewin J, Christiansen OB, Stephenson MD, Oladapo OT, Wijeyaratne CN, Small R, Bennett PR, Regan L, Goddijn M, Devall AJ, Bourne T, Brosens JJ, and Quenby S (2021) Sporadic miscarriage: evidence to provide effective care. Lancet 397(10285):1668-1674. https://doi.org/10.1016/S0140-6736(21)00683-8

Coomarasamy A, Dhillon-Smith RK, Papadopoulou A, Al-Memar M, Brewin J, Abrahams VM, Maheshwari A, Christiansen OB, Stephenson MD, Goddijn M, Oladapo OT, Wijeyaratne CN, Bick D, Shehata H, Small R, Bennett PR, Regan L, Rai R, Bourne T, Kaur R, Pickering O, Brosens JJ, Devall AJ, Gallos ID, and Quenby S (2021) Recurrent miscarriage: evidence to accelerate action. Lancet 397(10285):1675-1682. https://doi.org/10.1016/S0140-6736(21)00681-4

Wilson A, Hodgetts-Morton VA, Marson EJ, Markland AD, Larkai E, Papadopoulou A, Coomarasamy A, Tobias A, Chou D, Oladapo OT, Price MJ, Morris K, and Gallos ID (2021) Tocolytics for delaying preterm birth: a network meta‐analysis. Cochrane Database of Systematic Reviews 2021 Apr 22;4:CD014978. https://doi.org/10.1002/14651858.CD014978

Devall AJ, Papadopoulou A, Podesek M, Haas DM, Price MJ, Coomarasamy A, and Gallos ID (2021) Progestogens for preventing miscarriage: a network meta-analysis. Cochrane Database of Systematic Reviews 2021 Apr 19;4:CD013792. https://doi.org/10.1002/14651858.cd013792.pub2

Laios A, Jardim Portela SD, Papadopoulou A, Gallos ID, Otify M, and Ind T (2021) Ovarian transposition and cervical cancer. Best Practice & Research Clinical Obstetrics & Gynaecology [Epub ahead of print] https://doi.org/10.1016/j.bpobgyn.2021.01.013

Parry Smith WR, Papadopoulou A, Thomas E, Tobias A, Price MJ, Meher S, Alfirevic Z, Weeks AD, Hofmeyr GJ, Gülmezoglu AM, Widmer M, Oladapo OT, Vogel JP, Althabe F, Coomarasamy A, and Gallos ID (2020) Uterotonic agents for first-line treatment of postpartum haemorrhage: a network meta-analysis. Cochrane Database of Systematic Reviews 2020 Nov 24;11:CD012754. https://doi.org/10.1002/14651858.cd012754.pub2

Devall AJ, Papadopoulou A, Haas DM, Price MJ, Coomarasamy A, and Gallos ID (2020) Progestogens for preventing miscarriage: a network meta-analysis (Protocol). Cochrane Database of Systematic Reviews 2020 Nov 21;11:CD013792. https://doi.org/10.1002/14651858.CD013792

Oladapo OT, Okusanya BO, Abalos E, Gallos ID, and Papadopoulou A (2020) Intravenous versus intramuscular prophylactic oxytocin for the third stage of labour. Cochrane Database of Systematic Reviews 2020 Nov 9;11:CD009332 https://doi.org/10.1002/14651858.cd009332.pub4

Coomarasamy A, Devall AJ, Brosens JJ, Quenby S, Stephenson MD, Sierra S, Christiansen OB, Small R, Brewin J, Roberts TE, Dhillon-Smith R, Harb H, Noordali H, Papadopoulou A, Eapen A, Prior M, Di Renzo GC, Hinshaw K, Mol BW, Lumsden MA, Khalaf Y, Shennan A, Goddijn M, van Wely M, Al-Memar M, Bennett P, Bourne T, Rai R, Regan L, and Gallos ID (2020) Micronized vaginal progesterone to prevent miscarriage: a critical evaluation of randomized evidence. American Journal of Obstetrics and Gynecology 223(2):167-176. https://doi.org/10.1016/j.ajog.2019.12.006

Gallos ID, Papadopoulou A, Man R, Athanasopoulos N, Tobias A, Price MJ, Williams MJ, Diaz V, Pasquale J, Chamillard M, Widmer M, Tunçalp Ö, Hofmeyr GJ, Althabe F, Gülmezoglu AM, Vogel JP, Oladapo OT, and Coomarasamy A (2018) Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. Cochrane Database of Systematic Reviews 2018 Dec 19;12(12):CD011689. https://doi.org/10.1002/14651858.cd011689.pub3